ASPET (@aspet) 's Twitter Profile
ASPET

@aspet

American Society for Pharmacology & Experimental Therapeutics: Our members conduct research that develops disease-fighting medicines and therapeutic agents.

ID: 17631005

linkhttp://www.aspet.org calendar_today25-11-2008 20:49:05

8,8K Tweet

5,5K Followers

495 Following

ASPET (@aspet) 's Twitter Profile Photo

Acknowledge your peers for their outstanding achievements in #pharmacology! Nominations are open for the 2024 #ASPET Fellows, a prestigious honor bestowed on members for their work in advancing pharmacology. Submit by September 3 here: bit.ly/3OmLIJ2.

Acknowledge your peers for their outstanding achievements in #pharmacology! Nominations are open for the 2024 #ASPET Fellows, a prestigious honor bestowed on members for their work in advancing pharmacology. Submit by September 3 here: bit.ly/3OmLIJ2.
ASPET (@aspet) 's Twitter Profile Photo

Do you know a deserving colleague making great contributions to #pharmacology? Nominate them for an ASPET Scientific Achievement and Division Award to recognize and honor their work. Nominations will close on September 3, see here for more information: bit.ly/3AzfZw7.

Do you know a deserving colleague making great contributions to #pharmacology? Nominate them for an ASPET Scientific Achievement and Division Award to recognize and honor their work. Nominations will close on September 3, see here for more information: bit.ly/3AzfZw7.
ASPET (@aspet) 's Twitter Profile Photo

The August 2024 Highlighted Trainee Author for DMD is Pooja Hegde. Her research aims to identify the involvement of additional mechanisms underlying apparent pharmacokinetic changes in organic anion transporting polypeptide (OATP)-mediated DDIs. Read more: bit.ly/3STTLiy

The August 2024 Highlighted Trainee Author for DMD is Pooja Hegde. Her research aims to identify the involvement of additional mechanisms underlying apparent pharmacokinetic changes in organic anion transporting polypeptide (OATP)-mediated DDIs. Read more: bit.ly/3STTLiy
ASPET (@aspet) 's Twitter Profile Photo

Call for papers for Pharmacology Research & Perspectives (PR&P) that provide a comprehensive overview of the therapeutic potential of psychedelic compounds for various neuropsychiatric conditions, as well as the prospects and challenges in this exciting area. Learn more: ow.ly/QEHG50T27Vv

Call for papers for <a href="/PRandP_Journal/">Pharmacology Research & Perspectives (PR&P)</a> that provide a comprehensive overview of the therapeutic potential of psychedelic compounds for various neuropsychiatric conditions, as well as the prospects and challenges in this exciting area. Learn more: ow.ly/QEHG50T27Vv
ASPET (@aspet) 's Twitter Profile Photo

Contribute to the field of #pharmacology by submitting a session proposal to #ASPET2025 by August 29, 2024. There’s one more week remaining for an opportunity to share innovative science with the pharmacology community. Learn more here: bit.ly/3qH3i1o.

Contribute to the field of #pharmacology by submitting a session proposal to #ASPET2025 by August 29, 2024. There’s one more week remaining for an opportunity to share innovative science with the pharmacology community. Learn more here: bit.ly/3qH3i1o.
ASPET (@aspet) 's Twitter Profile Photo

Call for papers for special issue of Mol Pharm (ASPET) celebrating the top-tier research by attendees of the 4th Transatlantic ECI GPCR Symposium for early-career scientists. More information is available here: bit.ly/4fv3yFn. #pharmacology

Call for papers for special issue of <a href="/MolPharmJournal/">Mol Pharm (ASPET)</a> celebrating the top-tier research by attendees of the 4th Transatlantic ECI GPCR Symposium for early-career scientists. More information is available here: bit.ly/4fv3yFn. #pharmacology
ASPET (@aspet) 's Twitter Profile Photo

A small clinical trial to determine if plasma riboflavin levels can be used as a biomarker of BCRP inhibition, found a statistical increase of plasma riboflavin after treatment with an investigational drug that inhibits BCRP. Read more here: ow.ly/eZUx50T4QGb. Bristol Myers Squibb

A small clinical trial to determine if plasma riboflavin levels can be used as a biomarker of BCRP inhibition, found a statistical increase of plasma riboflavin after treatment with an investigational drug that inhibits BCRP. Read more here: ow.ly/eZUx50T4QGb. <a href="/bmsnews/">Bristol Myers Squibb</a>
ASPET (@aspet) 's Twitter Profile Photo

The August 2024 Highlighted Trainee Author for JPET (ASPET) is Sneha Rathi. Her work focuses on the development of therapies that can overcome the barriers posed by tumor biology and heterogeneity. Read her work here: ow.ly/qNVj50T4UuB. AbbVie #pharmacology

The August 2024 Highlighted Trainee Author for <a href="/JPET_Journal/">JPET (ASPET)</a> is Sneha Rathi. Her work focuses on the development of therapies that can overcome the barriers posed by tumor biology and heterogeneity. Read her work here: ow.ly/qNVj50T4UuB. <a href="/abbvie/">AbbVie</a> #pharmacology
ASPET (@aspet) 's Twitter Profile Photo

The August issue of TPharm is now live! Mentoring can provide personal and professional benefits for all involved. Learn about ASPET's work on facilitating mentoring opportunities for members and the new program MentorMatch. Read the issue here: bit.ly/470gLCa.

The August issue of TPharm is now live! Mentoring can provide personal and professional benefits for all involved. Learn about ASPET's work on facilitating mentoring opportunities for members and the new program MentorMatch. Read the issue here: bit.ly/470gLCa.
ASPET (@aspet) 's Twitter Profile Photo

August 29 is the deadline to submit a session proposal for #ASPET2025. Share an emerging research topic for consideration and capitalize on this opportunity to premier the hottest research that will excite the #pharmacology community. Learn more here: bit.ly/3qH3i1o.

August 29 is the deadline to submit a session proposal for #ASPET2025. Share an emerging research topic for consideration and capitalize on this opportunity to premier the hottest research that will excite the #pharmacology community. Learn more here: bit.ly/3qH3i1o.
ASPET (@aspet) 's Twitter Profile Photo

Mechanisms underlying cantharidin-induced toxicity remain unclear. The authors examined the chemical reactivity of cantharidin toward nucleophiles and characterized adducts of cantharidin with biologic amines in vitro and in mice. Read more: bit.ly/3Auo6hq.

Mechanisms underlying cantharidin-induced toxicity remain unclear. The authors examined the chemical reactivity of cantharidin toward nucleophiles and characterized adducts of cantharidin with biologic amines in vitro and in mice. Read more: bit.ly/3Auo6hq.
ASPET (@aspet) 's Twitter Profile Photo

Today is the last day to submit a session proposal for #ASPET2025. Don't miss this opportunity to share innovative research at the home for #pharmacology! Submit now: bit.ly/3qH3i1o.

ASPET (@aspet) 's Twitter Profile Photo

The authors found that CYP2C8*3 was associated with improved asthma symptom control among children. Follow-up in vitro studies demonstrated a role for CYP2C8 in regulating the epoxyoctadecenoic acid:dihydroxyoctadecenoic acid ratio. Read more: bit.ly/4fQVSxE DMD (ASPET)

The authors found that CYP2C8*3 was associated with improved asthma symptom control among children. Follow-up in vitro studies demonstrated a role for CYP2C8 in regulating the epoxyoctadecenoic acid:dihydroxyoctadecenoic acid ratio. Read more: bit.ly/4fQVSxE <a href="/DMD_Journal/">DMD (ASPET)</a>
ASPET (@aspet) 's Twitter Profile Photo

Researchers found that empagliflozin, used to treat Type II Diabetes, reduces peripheral neuropathy in a rodent model when given before eating. It suggests that taking an SGLT2 inhibitor before eating could diminish peripheral neuropathy. Read more: bit.ly/4dI3MYD

Researchers found that empagliflozin, used to treat Type II Diabetes, reduces peripheral neuropathy in a rodent model when given before eating. It suggests that taking an SGLT2 inhibitor before eating could diminish peripheral neuropathy. Read more: bit.ly/4dI3MYD
ASPET (@aspet) 's Twitter Profile Photo

The authors determined that the modifiable mini parallel tube model, which closely mimics the physiologic dispersion model, was superior to the widely used yet unphysiologic well-stirred model for predicting hepatic drug clearance. Read the article here: bit.ly/4cAcG8V.

The authors determined that the modifiable mini parallel tube model, which closely mimics the physiologic dispersion model, was superior to the widely used yet unphysiologic well-stirred model for predicting hepatic drug clearance. Read the article here: bit.ly/4cAcG8V.
ASPET (@aspet) 's Twitter Profile Photo

Call for papers for special issue of Mol Pharm (ASPET) celebrating the top-tier research by attendees of the 4th Transatlantic ECI GPCR Symposium for early-career scientists. More information is available here: bit.ly/4fv3yFn. #pharmacology

Call for papers for special issue of <a href="/MolPharmJournal/">Mol Pharm (ASPET)</a> celebrating the top-tier research by attendees of the 4th Transatlantic ECI GPCR Symposium for early-career scientists. More information is available here: bit.ly/4fv3yFn. #pharmacology
ASPET (@aspet) 's Twitter Profile Photo

Today is the deadline to nominate someone deserving of an ASPET Scientific Achievement and Division Award. Learn more here: bit.ly/3AzfZw7. #pharmacology

Today is the deadline to nominate someone deserving of an ASPET Scientific Achievement and Division Award. Learn more here: bit.ly/3AzfZw7. #pharmacology
ASPET (@aspet) 's Twitter Profile Photo

Many G protein activity biosensor tools have become available and choosing among them can be challenging. Researchers from Boston U Chobanian & Avedisian School of Medicine review features and capabilities of different optical biosensor designs to facilitate rational selection. Read more here: bit.ly/3ARcBRk

Many G protein activity biosensor tools have become available and choosing among them can be challenging. Researchers from <a href="/BUMedicine/">Boston U Chobanian & Avedisian School of Medicine</a> review features and capabilities of different optical biosensor designs to facilitate rational selection. Read more here: bit.ly/3ARcBRk
ASPET (@aspet) 's Twitter Profile Photo

ASPET is pleased to announce the 10 recipients for its 2024-2025 Washington Fellows program. These early-career scientists will be learning about science advocacy issues and engaging with public policy experts. Meet the new fellows here: bit.ly/3ASTExy. #sciencepolicy

ASPET is pleased to announce the 10 recipients for its 2024-2025 Washington Fellows program. These early-career scientists will be learning about science advocacy issues and engaging with public policy experts. Meet the new fellows here: bit.ly/3ASTExy. #sciencepolicy